CharlesABirbaraMD

PubMed

• 26 citations
  Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1-3 studies
  Dafna D. Gladman, Arthur Kavanaugh, Juan J. Gomez-Reino, Jürgen Wollenhaupt, Maurizio Cutolo, Georg Schett, Eric Lespessailles, Benoit Guerette, N. Delev, L. Teng, Chr...> ;RMD Open. 2018 Jun 1
• 3 citations
  Effect of psoriatic arthritis on ixekizumab clinical outcomes in moderate-to-severe psoriasis patients: A post hoc analysis.
  Alice B. Gottlieb, Kim A. Papp, C. Birbara, Catherine L Shuler, Russel Burge, J. Erickson, Lisa Kerr, Philip J. Mease> ;Journal of the American Academy of Dermatology. 2018 Mar 17
• 25 citations
  Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis.
  C. Birbara, Eugene J. Dabezies Jr, Aimee M. Burr, Robert J. Fountaine, Michael D. Smith, Mark T. Brown, Christine R. West, Rosalin Arends, Kenneth M. Verburg> ;Journal of Pain Research. 2018 Jan 8
• 181 citations
  Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)
  Christopher J Edwards, Francisco J. Blanco, Jeffrey Crowley, C. Birbara, Janusz Jaworski, Jacob A. Aelion, R. Stevens, Adele R. Vessey, Xiaojiang Zhan, Paul Bird> ;Annals of the Rheumatic Diseases. 2016 Jun 1
• 13 citations
  Final 10-year effectiveness and safety results from study DE020: adalimumab treatment in patients with rheumatoid arthritis and an inadequate response to standard therapy
  Daniel E. Furst, Arthur Kavanaugh, Stefan Florentinus, Hartmut Kupper, M. Karunaratne, C. Birbara> ;Rheumatology. 2015 Dec 1
• 30 citations
  Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial
  Mittie K. Doyle, Mahboob Rahman, Bart Frederick, C. Birbara, Dick de Vries, Gary Toedter, Xiaoying Wu, Dion Chen, Veena K. Ranganath, Mark E. Westerman, Daniel E. Furst> ;Rheumatology. 2013 Jul 1
• 29 citations
  Intra-articular hylastan versus steroid for knee osteoarthritis.
  Lawrence R Housman, Nigel K Arden, Thomas J. Schnitzer, C. Birbara, Thierry Conrozier, Nathan Wei, Barry Bockow, David Waddell, Hasan Tahir, Anthony Hammond, Philippe ...> ;Knee Surgery, Sports Traumatology, Arthroscopy. 2014 Jul 1
• Response to letter by Ackermann.
  > ;Pain. 2012 Mar 31
• 86 citations
  Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee pain.
  Thomas J. Schnitzer, Nancy E Lane, C. Birbara, Michael D. Smith, S. L. Simpson, Mark T. Brown> ;Osteoarthritis and Cartilage. 2011 Jun 1
• 489 citations
  Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee
  Nancy E Lane, Thomas J. Schnitzer, C. Birbara, Masoud Mokhtarani, David L. Shelton, Michael D. Smith, Mark T. Brown> ;The New England Journal of Medicine. 2010 Oct 13
• 196 citations
  Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)
  P. J. Mease, P Ory, John T. Sharp, Christopher T. Ritchlin, F. Van den Bosch, F Wellborne, C. Birbara, Glen T D Thomson, Renee J. Perdok, John R. Medich, Robert L. Won...> ;Annals of the Rheumatic Diseases. 2009 May 1
• 135 citations
  Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and mainte...
  D. van der Heijde, A. Kavanaugh, Dafna D. Gladman, C Antoni, Gerald G. Krueger, Cynthia Guzzo, B. Zhou, Lisa T. Dooley, K. de Vlam, P. Geusens, C. Birbara, D. Halter, ...> ;Arthritis and Rheumatism. 2007 Aug 1
• 148 citations
  Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial
  A. Kavanaugh, Gerald G. Krueger, A. Beutler, Cynthia Guzzo, B. Zhou, Lisa T. Dooley, Philip J. Mease, Dafna D. Gladman, K. de Vlam, Piet Geusens, C. Birbara, D. Halter...> ;Annals of the Rheumatic Diseases. 2006 Nov 17
• 17 citations
  Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies.
  C Birbara, Gary E. Ruoff, E Sheldon, C Valenzuela, Anthony Rodgers, Richard A. Petruschke, David J. Chang, Andrew M. Tershakovec> ;Current Medical Research and Opinion. 2006 Jan 1
• 532 citations
  Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
  C Antoni, Gerald G. Krueger, K. de Vlam, C. Birbara, A. Beutler, Cynthia Guzzo, B. Zhou, Lisa T. Dooley, Arthur Kavanaugh> ;Annals of the Rheumatic Diseases. 2005 Aug 1
• 400 citations
  Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthriti...
  Daniel E. Furst, Michael Schiff, Roy Fleischmann, Vibeke Strand, C. Birbara, Daniele Compagnone, Steven A. Fischkoff, Elliot Chartash> ;The Journal of Rheumatology. 2003 Dec 1
• 81 citations
  Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability—a randomized, placebo-controlled, 3...
  C. Birbara, Anthony D Puopolo, David R Munoz, Eric A Sheldon, Antoinette Mangione, Norman R. Bohidar, Gregory P. Geba> ;The Journal of Pain. 2003 Aug 1
• 1362 citations
  Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: ...
  Michael E. Weinblatt, Edward C. Keystone, Daniel E. Furst, Larry W. Moreland, Michael H. Weisman, C. Birbara, Leah A. Teoh, Steven A. Fischkoff, Elliot Chartash> ;Arthritis and Rheumatism. 2003 Jan 1
• 43 citations
  Meningococcal infections at an army training center
  Charles A. Birbara> ;The American Journal of Medicine. 1968 Feb 1
• 179 citations
  Efficacy and safety of tanezumab in the treatment of chronic low back pain
  Nathaniel P. Katz, David G. Borenstein, C. Birbara, Candace Bramson, Mary Anne Nemeth, Michael D. Smith, Mark T. Brown> ;Pain. 2011 Oct 1
• 53 citations
  Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life.
  Paul Emery, Mark Kosinski, Tracy Li, Marie Martin, G. Rhys Williams, Jean-Claude Becker, Bonnie Blaisdell, John E. Ware, C. Birbara, Anthony S. Russell> ;The Journal of Rheumatology. 2006 Apr 1
• 195 citations
  Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab.
  Jeffrey L Kaine, Alan Kivitz, C. Birbara, Allison Y Luo> ;The Journal of Rheumatology. 2007 Feb 1
• 899 citations
  Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.
  Mark C. Genovese, Jean-Claude Becker, Michael Schiff, Michael E. Luggen, Yvonne Sherrer, Joel M. Kremer, C. Birbara, Jane Box, Kannan Natarajan, Isaac Nuamah, Tracy Li...> ;The New England Journal of Medicine. 2005 Sep 15
• 33 citations
  Frequency, predictors, and economic impact of upward dose adjustment of infliximab in managed care patients with rheumatoid arthritis.
  Daniel A. Ollendorf, Elena Massarotti, C. Birbara, Somali Misra Burgess> ;Journal of Managed Care Pharmacy. 2005 Jun 1
• 22 citations
  Rabeprazole for the prevention of recurrent erosive or ulcerative gastro-oesophageal reflux disease. Rabeprazole Study Group.
  C. Birbara, Jeffrey Breiter, Carlos Perdomo, William F. Hahne> ;European Journal of Gastroenterology & Hepatology. 2000 Aug 1
• Join now to see all